These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34238461)

  • 1. The vasopressin-aquaporin-2 pathway syndromes.
    Valenti G; Tamma G
    Handb Clin Neurol; 2021; 181():249-259. PubMed ID: 34238461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin-aquaporin-2 pathway: recent advances in understanding water balance disorders.
    Ranieri M; Di Mise A; Tamma G; Valenti G
    F1000Res; 2019; 8():. PubMed ID: 30800291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vasopressin V2 receptor-related pathologies: congenital nephrogenic diabetes insipidus and nephrogenic syndrome of inappropiate antidiuresis].
    Morin D
    Nephrol Ther; 2014 Dec; 10(7):538-46. PubMed ID: 25449762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nephrogenic syndrome of inappropriate antidiuresis].
    Nawal B; Izzedine H; Haddiya I; Bentata Y
    Pan Afr Med J; 2019; 32():210. PubMed ID: 31312322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updates and Perspectives on Aquaporin-2 and Water Balance Disorders.
    Noda Y; Sasaki S
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.
    Milano S; Carmosino M; Gerbino A; Svelto M; Procino G
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
    Bichet DG; Bockenhauer D
    Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic deletion of the nuclear factor of activated T cells 5 in collecting duct principal cells causes nephrogenic diabetes insipidus.
    Petrillo F; Chernyakov D; Esteva-Font C; Poulsen SB; Edemir B; Fenton RA
    FASEB J; 2022 Nov; 36(11):e22583. PubMed ID: 36197017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin type-2 receptor and aquaporin-2 water channel mutants in nephrogenic diabetes insipidus.
    Deen PM; Knoers NV
    Am J Med Sci; 1998 Nov; 316(5):300-9. PubMed ID: 9822112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gain-of-function mutations of the V2 vasopressin receptor in nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a cell-based assay to assess constitutive water reabsorption.
    Ranieri M; Tamma G; Pellegrino T; Vezzi V; Ambrosio C; Grò C; Di Mise A; Costa T; Valenti G; Cotecchia S
    Pflugers Arch; 2019 Oct; 471(10):1291-1304. PubMed ID: 31486901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.
    Gao C; Higgins PJ; Zhang W
    Cells; 2020 Sep; 9(10):. PubMed ID: 32993088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of AQP2 water channels by protein kinase A: therapeutic strategies for congenital nephrogenic diabetes insipidus.
    Ando F
    Clin Exp Nephrol; 2021 Oct; 25(10):1051-1056. PubMed ID: 34224008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
    Robben JH; Knoers NV; Deen PM
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F257-70. PubMed ID: 16825342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aquaporin 2 mutations in nephrogenic diabetes insipidus.
    Loonen AJ; Knoers NV; van Os CH; Deen PM
    Semin Nephrol; 2008 May; 28(3):252-65. PubMed ID: 18519086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel signalling pathways in nephrogenic syndrome of inappropriate antidiuresis: functional implication of site-specific AQP2 phosphorylation.
    Venneri M; Vezzi V; Di Mise A; Ranieri M; Centrone M; Tamma G; Nejsum LN; Valenti G
    J Physiol; 2024 Jul; 602(13):3169-3189. PubMed ID: 36823952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrogenic diabetes insipidus.
    Bichet DG
    Am J Med; 1998 Nov; 105(5):431-42. PubMed ID: 9831428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrogenic diabetes insipidus.
    Bichet DG
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):96-104. PubMed ID: 16580609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of three vasopressin receptor 2 variants: an apparent polymorphism (V266A) and two loss-of-function mutations (R181C and M311V).
    Armstrong SP; Seeber RM; Ayoub MA; Feldman BJ; Pfleger KD
    PLoS One; 2013; 8(6):e65885. PubMed ID: 23762448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus.
    Olesen ET; Rützler MR; Moeller HB; Praetorius HA; Fenton RA
    Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12949-54. PubMed ID: 21768374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrogenic Diabetes Insipidus.
    Balla A; Hunyady L
    Exp Suppl; 2019; 111():317-339. PubMed ID: 31588538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.